That's exactly right, growing revenues, margins and lowering...

That's exactly right, growing revenues, margins and lowering expenses, expanding product ranges and lines, people much more intelligent than most posters on an online forum behind it, expanding into larger markets such as UAE and hopefully entering India and China, a first of its kind product that is the only one of its kind in market. Yes, things can go wrong if those things don't take off, however, this stock was massive years ago for its potential hence why it traded at $1.80. And it did that due to the potential seen in the company , which is only now even slightly being realised. Still a long way to go, company wise and and I believe the share price to follow based on stronger earnings. Oh and the icing on the cake of the immuno-therapys is there too. Exciting times